Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)

التفاصيل البيبلوغرافية
العنوان: Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)
المؤلفون: Ilaria Mastrorosa, Roberta Gagliardini, Francesco Segala, Annalisa Mondi, Patrizia Lorenzini, Carlotta Cerva, Eleonora Taddei, Francesca Bai, Alessandra Vergori, Negri Marcantonio, Carmela Pinnetti, Stefania Cicalini, Rita Murri, Valentina Mazzotta, Marta Camici, Silvia Mosti, Teresa Bini, Gaetano Maffongelli, Alessia Beccacece, Eugenia Milozzi, Marco Iannetta, Silvia Lamonica, Marisa Fusto, Maria Maddalena Plazzi, Sandrine Ottou, Miriam Lichtner, Massimo Fantoni, Massimo Andreoni, Loredana Sarmati, Roberto Cauda, Enrico Girardi, Emanuele Nicastri, Antonella D'Arminio Monforte, Fabrizio Palmieri, Antonella Cingolani, Francesco Vaia, Andrea Antinori, ESCAPE Study Group
المصدر: SSRN Electronic Journal.
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: History, Polymers and Plastics, Business and International Management, Industrial and Manufacturing Engineering
تدمد: 1556-5068
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c69a038fc9bacea3eb97e6762aea7a45
https://doi.org/10.2139/ssrn.4289473
رقم الأكسشن: edsair.doi...........c69a038fc9bacea3eb97e6762aea7a45
قاعدة البيانات: OpenAIRE